Dental laboratory technicians who missed Roland in Chicago and at IDS in Germany might not have seen the debut of Roland's brand-new wet mill, the DWX-4W, but there is another opportunity. 

On Tuesday, March 17, Roland will host a lively webcast with Brian Brooks and Fernando Catania. They will give updates from both shows and learn all about this latest technology from Roland. Webcase attendees also will hear what customers and show attendees thought.

Issues that will be addressed include different types of milling jobs with a wet-only solution, and whether or not to combine wet and dry milling.

The webcast will be from 10 a.m. - 11 a.m. Tuesday. To register, go to https://attendee.gotowebinar.com/register/7735518764633900290.

SAN DIEGO, CA – The Argen Corporation, the world’s largest manufacturer of dental gold alloys and a leading innovator in digital dentistry solutions, has hired Robin Bartolo, CDT, as Vice President of International Sales. Bartolo will continue to drive global sales and develop Argen’s strategic partnerships with dealers and dental laboratories nationwide.

“We are extremely excited and fortunate to welcome Robin into the Argen Family,” says Anton Woolf, CEO of the Argen Corporation. “Robin brings with him amazing global sales and marketing experience, launching new products and accelerating the growth of entire market segments. He has been a key influencer for major dental manufacturers and has a proven record of success.”

Bartolo joins Argen after holding the position of Sales Manager at Glidewell Laboratories for 6 years. Prior to his time with Glidewell, he spent 3 years as the global director of sales and marketing for the Gemological Institute of America. He has held positions of international sales manager for Kerr Dental Laboratory Products, and sales manager for Vident, Inc. Bartolo graduated with honors from Southern Illinois University at Carbondale in 1984.

During his time with Glidewell Laboratories, Bartolo was instrumental in the launch of full-contour monolithic zirconia crowns and bridges. The introduction of monolithic zirconia created an entirely new market segment that caused a monumental shift in the dental industry. 

“This is a very exciting time to be involved in the dental industry,” Bartolo says. “I’m extremely proud to join Argen’s international sales team and look forward to supporting global alloy sales while educating our partners about the new digital workflow.”

Copenhagen, March 10th, 2015 –3Shape is unveiling several new solutions for dental laboratories this week at the International Dental Show (IDS) in Cologne, Germany.

The new solutions include upgraded versions of its dental lab scanners, two new lab scanners and the latest release of its industry-leading CAD software solution, Dental System™ 2015.

Highlights of the releases include upwards of 30% faster scanning speeds and greater accuracy for the benchtop scanners as well as new indications, tools and third party integrations for its software.

“Our new CAD/CAM solutions demonstrate 3Shape’s commitment to providing dental labs with more opportunities to grow their product portfolios and serve more customers,” says Flemming Thorup, president & CEO at 3Shape.

3Shape scanners boost speed and performance

The new versions of the D-series benchtop scanner are the D750 and D850, which are major upgrades of the former D700 and D800 scanner models. The two, along with the presently available D900L, now feature a new technology platform combined with a larger interior space and blue LED for reduced scan noise.

3 years of LABcare™ included

In addition, the D750, D850 and D900L also include a three year subscription to 3Shape LABcare™. The three year LABcare™ bundle features free yearly software updates, product training and service. The subscription offer is valid up until September 30, 2015.

The D-series also contains the D500 lab scanner and includes a cost-effective option to extend the LABcare™ package to three years.

Two new D-series lab scanners released: D2000 and D1000

3Shape introduced two new lab scanners, the D2000 and D1000, two weeks ago at the Midwinter Meeting in Chicago. The two lab scanners are equipped with 4 x 5.0 MP cameras and high-quality mechanics to improve scanning accuracy and the aforementioned new multi-line technology for increased scanning speeds.

NEW D2000 – reduces handling time by 40%

The D2000 benchtop scanner includes several other new features like, “All-in-One” scanning and a large interior with room for two models.

D-series lab scanners video: https://ow.ly/JXhTw

Malvern, PA – DentalEZ^®, a supplier of integrated products and services for dental health professionals worldwide, has introduced various updates to its classic DentalEZ brand. With an official tagline of “Integrated Solutions,” and now simply referred to as “DentalEZ,” the Company unveiled some of its recent rebranding efforts such as a new color palette, logo, and a freshly designed exhibit booth at this year’s Chicago Midwinter Dental Meeting. 

With the acquisition of various new companies and products throughout the years, DentalEZ has established a diverse yet very broad assortment of products. The company’s current rebranding efforts will ensure that its entire portfolio is streamlined in order to tell a clear story about its ever-growing product offerings and organization.

Throughout 2015, DentalEZ will begin to slowly phase out the use of individual brand logos and introduce a single all-encompassing DentalEZ logo. All DentalEZ product categories will also be more consistent with the new DentalEZ name and tagline:

Columbia Dentoform^® Teaching Solutions

DentalEZ^®Equipment Solutions

NevinLabs^™Workstation Solutions

RAMVAC^®Utility Solutions

StarDental^®Instrument Solutions

“With this more unified and simplistic approach to branding, we plan to increase clarity of what our company offerings are, while raising awareness and understanding across all product lines of DentalEZ and our many ‘Integrated Solutions,’” remarked Lisa Lee, Vice President of Sales and Marketing. “In the next year we will have gradual updates of all materials, websites, and signage. We truly look forward to an exciting new era here at DentalEZ.”

Treating a common gum condition in chronic kidney disease (CKD) patients could significantly reduce their risk of potentially fatal heart disease, Aston University researchers say.

Over 10% of the adult population have CKD and those affected often have poor health outcomes due to an increased incidence of cardiovascular disease compared to the general population. CKD progressively worsens kidney function, raises blood pressure, and can cause progressive vascular injury and heart disease.

Recent research suggests that increased mortality in people with CKD may be linked with chronic inflammatory conditions such as periodontitis, which causes gum inflammation, loss of the bone that supports the teeth and ultimately tooth loss.

Previous studies have revealed that more than 85% of people with CKD have inflammatory gum problems, caused by inadequate removal of dental plaque from between the tooth and gum margin and made worse by impaired immunity and wound healing. Experts have identified that bacteria in the mouth can enter the bloodstream through periodontal conditions, causing blood cells to malfunction and leading to clots and narrowing of the arteries.

Aston academic, Dr. Irundika Dias, is leading a study into the underlying causes of increased cardiovascular disease and outcomes of accelerated progression observed in people with CKD and periodontitis. She will observe how successfully treating periodontitis reduces oxidised lipids and inflammatory cell activity in people with CKD, thereby lowering their risk of life-threatening heart disease.

Dr. Dias, of Aston's School of Health and Life Sciences, said: "This project has the potential to make a real difference for people with CKD. If we can prove managing periodontitis reduces the threat of cardiovascular diseasethen it may well represent an efficient and cost effective treatment for CKD.

"In conjunction with our study, I will be talking to dental schools about alternative ways of helping periodontitis patients. It is vitally important to keep your gums healthy and have regular dental check-ups to avoid the onset of a disease that is very common, poorly appreciated by the public and causes tooth loss resulting in reduced quality of life."

The study will involve 80 people, including 60 people with CKD, both withand without periodontitis and healthy volunteers. This will include a group of 20 people with CKD and periodontitis who will be randomised to have the gum condition clinically treated over a 12 month period. These volunteers will be reviewed at three monthly intervals to assess markers of cardiovascular disease, such as oxidative stress biomarkers in the blood and arterial stiffness.

The project is part of a collaboration between Dr. Dias and Professor Helen Griffiths of Aston's School of Health and Life Sciences, Professor Iain Chapple, Head of Periodontology at the University of Birmingham, and Professor Paul Cockwell, Consultant Nephrologist at University Hospitals Birmingham NHS Foundation Trust. This partnership has allowed Dr. Dias to obtain vital samples from patients in Birmingham Hospitals from those with and without periodontitis.

Source: Science Daily

Andres Pinto, an orofacial pain and oral medicine specialist at Case Western Reserve University School of Dental Medicine, often feels like the doctor in the television series House, who solves medical mysteries each week.

Pinto is among about 700 facial pain and oral medicine specialists nationally to whom patients often turn when their own doctors are unable to identify and treat complex and rare medical conditions. In fact, according to a new study Pinto conducted with input from fellow members of the American Academy of Oral Medicine (AAOM), patients see, on average, 2.2 doctors over 17 months before visiting facial pain and oral medicine specialists, hoping to finally find the cause of their discomfort.

Unfortunately, Pinto said, the delay in getting treatment allows the pain to escalate from acute to the chronic stage, reducing the patient's quality of life dramatically.

Patients come from as far as the Gulf States to be evaluated and treated by the team of pain specialists at the CWRU dental school—one of just seven inclusive teams nationally and the only one in Ohio with specially trained head and neck radiologists, oral and maxillofacial medicine and orofacial pain clinicians and oral and maxillofacial pathologists all within one clinical setting.

Pinto, DMD, MPH, FDS, RCSEd, in the dental school's Department of Oral and Maxillofacial Medicine and Diagnostics Sciences, heads the university's orofacial pain and oral medicine group, which tackles ailments with such exotic names as, idiopathic persistent facial pain, oral chemosensory disorders and glossodynia.

To better understand the work by pain specialists at Case Western Reserve and others nationally, Pinto recently led a research team to survey AAOM members.

The report, which updates a similar industry survey in 1996 and a national database analysis in 2001, is the first to describe in detail the types of patients the specialists see in the United States and the largest to describe the field's characteristics, Pinto said.

Practitioners (74 in 20 states) provided information about patient demographics, referring health-care providers, medical issues, diagnoses and themselves.

Among the findings, reported in April's Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology article, "The practice of oral medicine in the United States in the twenty-first century: an update":

Almost half of the specialists (46%) practiced in dental schools. About a third (31%) practiced in hospitals, and 18% practiced in combined settings. Only 5% were in private practice.

Most specialists received referrals from general dentists and otolaryngologists, hematologists, oncologists, radiation oncologists, rheumatologists and dermatologists. If postdoctoral training in oral medicine and facial pain management is offered, more patients in that particular state will be referred for the services.

The leading cause of the referral was oral lesions, followed by orofacial pain, dry mouth, burning mouth and oral sores or ulcers. The tongue and gums were predominant sites for pain, but less so for teeth and lips. About one-third of the referred patients reported pain in at least two locations.

Oral lesions and pain caused by oral lichen planus (a skin disease that can occur in the mouth) was the main reason many sought treatment, followed by problems with the salivary glands.

The researchers also examined the link between oral and overall health, and what diseases--such as heart disease, endocrine, rheumatoid and digestive issues--may be associated with oral findings.

The average age of the patients was 57. Nearly twice as many of the patients were women.

Pinto said the study highlighted several changes in the field since the last survey 19 years ago:

Specialists are seeing more oncology-related oral treatments, from preparation for cancer therapy to management of complications during therapy.

The pattern of patient referrals demonstrates the breadth of the interprofessional practice with ear, nose and throat surgeons, dermatologists and oncologists, general practice dentists and other health-care providers.

Pinto established the team 14 months ago at the CWRU patient clinics. The clinic is seeing between 50 and 60 patients with complex pain issues weekly.

Source: Science Daily

CHICAGO, March 31, 2015 /PRNewswire-USNewswire/ -- According to the Oral Cancer Foundation, more than 43,000 new cases of oral cancer will be diagnosed this year, and oral cancer is expected to cause more than 8,000 deaths—about one death per hour.

In observance of Oral Cancer Awareness Month, the Academy of General Dentistry (AGD) recommends that patients visit their dentists every six months for a dental exam. Dental exams not only help to decrease a patient's risk of oral diseases, such as cavities and gum disease, but they also may help to diagnose potentially life-threatening medical conditions, such as oral cancer.

"Checking for oral cancer is quick and painless," says AGD Spokesperson Vincent Mayher, DMD, MAGD. "Your dentist will feel for lumps or irregular tissue changes in the neck, throat, cheeks, and mouth, and look for any sores or discoloration."

Oral cancer is particularly dangerous because it can go unnoticed by patients in its preliminary stages. In many cases, however, dentists can identify its early signs and symptoms.

"General dentists are the first line of defense against oral cancer, and early detection is key to increasing survival rates," he says. "If it is not diagnosed and treated in its early stages, oral cancer can be deadly."

Scientists are not sure of the exact cause of oral cancer. However, risk factors include tobacco use, excessive alcohol use, age, gender (oral cancer strikes men twice as often as it does women), and race (oral cancer occurs twice as frequently in African Americans than Caucasians). Research also has uncovered a connection between the human papillomavirus (HPV), the most common sexually transmitted infection in the U.S., and oral cancer.

"In addition to brushing and flossing your teeth twice daily, scheduling two visits with your general dentist each year helps to ensure that any concerns are caught early on," says Dr. Mayher.

To bring further attention to this topic, the AGD Foundation, the philanthropic arm of the AGD, will host free oral cancer screenings with oral health education for the general public at AGD 2015, the AGD's annual meeting, in San Francisco. In addition, the AGD Foundation aims to provide AGD's 39,000 members with free or low-cost continuing education on the latest oral cancer-identification techniques, and a webinar series on how to better screen during routine dental exams. The AGD Foundation is proud to be an intellectual partner of the Global Oral Cancer Forum—an international assembly of passionate professionals focused on building awareness gaps on innovation, prevention, patient care, technology, and services.

To locate an AGD dentist in your area, use the Find an AGD Dentist tool at www.KnowYourTeeth.com.

Madison, Wis. -- November 25th, 2014 -- Patients who have passed up cosmetic dentistry treatment because they couldn’t pay for it now have another reason to find an AACD Member Dentist.

The American Academy of Cosmetic Dentistry (AACD) has partnered with SimplePay, a patient financing provider that offers services with no required credit checks and 0% interest. These features make SimplePay an excellent supplement to other patient financing options dentists already use.

Normally $199/month, AACD member dentists can now receive this benefit for free, which means with SimplePay, AACD member dentists can increase their case acceptance while helping patients get the smiles of their dreams. Another benefit of SimplePay is that even if a patient misses a payment, the dentist still gets paid.

“One of the best things about SimplePay is that we can provide a competitive edge to the dental office,” said Shaleen Shah, SimplePay CEO. “We recognize that we can make a great impact to the cosmetic dental office’s bottom line by helping patients afford the treatments and say ‘yes’ to recommended care.”

According to AACD’s 2013 State of the Cosmetic Dentistry Industry Survey, all dentists who offered third-party financing reported that the financing helped them get a “yes” from patients who sought dental treatment. Now, with SimplePay as an additional option for financing at no cost to AACD member dentists, more patients than ever will be able to say “yes.”

For more information about SimplePay, click here.

About the AACD

The AACD is the world’s largest non-profit member organization dedicated to advancing excellence in comprehensive oral care that combines art and science to optimally improve dental health, esthetics, and function. Comprised of more than 6,400 cosmetic dental professionals in 80 countries worldwide, the AACD fulfills its mission by offering superior educational opportunities, promoting and supporting a respected Accreditation credential, serving as a user-friendly and inviting forum for the creative exchange of knowledge and ideas, and providing accurate and useful information to the public and the profession. For more information, visit www.aacd.com.

Palm Beach Gardens, FL – April 7, 2015 – An electronic poster presentation featuring BIOMET 3i custom implants and carefully documenting the anchorage of bone to implant surfaces, conducted by Robert Liddell, Niloufar Khosravi, Elnaz Ajami, and J.E. Davies has taken first place at the 30th Annual meeting of the Academy of Osseointegration.

The poster entitled, “A New Parameter to Assess the Osseointegration Potential of an Implant Surface” is the culmination of animal experiments involving 244 surgical procedures over a period of three months with a post-op follow up period of up to six months. The researchers used micro- and nano-surfaced implants and measured the force to remove the implant from bone over a range of time points. By fitting their data to curves according to a mathematical equation formulated by Liddell, they arrived at a unique parameter that provides the rate of osseointegration—and thus the osseointegration potential of the implant.**

The new parameter, which they called “Tau”, represents a true breakthrough in the understanding of the role played by the implant surface in the mechanisms of osseointegration, since it determines the rate of osseointegration and allows the performance of different implant surfaces to be compared.

In the study, the custom made 3i T3^® implants with DCD^® demonstrated significantly faster early osseointegration when compared to micro-surfaced implants. However, the longer-term osseointegration results of both implant surface designs showed similar results, as is reported clinically.

“Now we have a mathematical parameter that allows us to compare the osseointegration potential of different implant surfaces,” Davies said. “This approach is clinically relevant and, for the first time, provides insight into the biologic significance of implant surface design.”

The poster can be found at the following link: https://ao2015.sessionupload.com/ePosters/PosterViewer?r=NTk5Ng==

About BIOMET 3i

BIOMET 3i LLC is a leading manufacturer of dental implants, abutments and related products. Since its inception in 1987, BIOMET 3i has been on the forefront in developing, manufacturing and distributing oral reconstructive products, including dental implant components and bone and tissue regenerative materials. The company also provides educational programs and seminars for dental professionals around the world. BIOMET 3i is based in Palm Beach Gardens, Florida, with operations throughout North America, Latin America, Europe and Asia-Pacific. For more information about BIOMET 3i, please visit www.biomet3i.com or contact the company at (800) 342-5454; outside the U.S. dial (561) 776-6700.

*Dr. Davies has a financial relationship with BIOMET 3i resulting from speaking engagements, consulting engagements, or other retained services.

**The study was funding in part by BIOMET 3i.

The NYUCD/Henry Schein Cares Global Student Outreach Program headed to Granada, Nicaragua on September 20, 2014 to provide free dental care to children and adults at Casa de los Tres Mundos. This trip marked NYUCD's seventh return to Nicaragua, with the team delivering care to approximately 1,000 patients from Colegio San Antonio. From October 14-17, 2014, students attending Poughkeepsie City School District Schools also received complete dental treatment, with no required out-of-pocket cost to families, thanks to the New York University College of Dentist/Henry Schein Cares Global Student Outreach Program.

Next, the program will head to Kathmandu, Nepal from October 30-November 9, 2014.

As part of this program, NYUCD professors, dental students, dental residents and dental hygienists participate in mission trips, providing free oral health care education, emergency dental services, screenings, prevention, sealant application, and restorative treatment to underserved communities throughout the United States, Latin America, Central America, India, South Asia, and Africa.

The Program is the result of a partnership between NYUCD, Henry Schein, Inc. - the world’s largest provider of health care products and services to office-based dental, animal health and medical practitioners - and local partners in each participating community. Through its corporate social responsibility program, Henry Schein Cares, the Company provides all of the dental supplies needed for each of the program’s missions taking place throughout the year. Since the program’s inception, care has been provided to more than 50,000 children and adults in underserved communities.

About New York University College of Dentistry

New York University College of Dentistry (NYUCD) is the third oldest and the largest dental school in the US, educating more than 8 percent of all dentists. NYUCD has a significant global reach and provides a level of national and international diversity among its students that is unmatched by any other dental school. https://www.nyu.edu/dental/

About Henry Schein Cares

Henry Schein Cares, Henry Schein's global corporate social responsibility program, stands on four pillars: engaging Team Schein Members to reach their potential, ensuring accountability by extending ethical business practices to all levels within Henry Schein, promoting environmental sustainability, and expanding access to health care for underserved and at-risk communities around the world. Health care activities supported by Henry Schein Cares focus on three main areas: advancing wellness, building capacity in the delivery of health care services, and assisting in emergency preparedness and relief. Firmly rooted in a deep commitment to social responsibility and the concept of enlightened self-interest championed by Benjamin Franklin, the philosophy behind Henry Schein Cares is a vision of "doing well by doing good." Through the work of Henry Schein Cares to enhance access to care for those in need, the Company believes that it is furthering its long-term success.